The global non-vascular stents market size is expected to reach USD 2.27 billion by 2030, registering a CAGR of 4.8% from 2024 to 2030. The market is expected to witness lucrative growth during the forecast period due to technological advancements in the non-vascular stents and rise in the adoption of minimally invasive surgeries across the world.
Technological advancements such as the development of radioactive & biodegradable stents, advanced stent designs & change in material composition, and newer stent placement techniques, such as Endoscopic Ultrasound-guided (EUS) stenting, are expected to help in the growth of the non-vascular stents market over the forecast period. Various materials such as metallic stents, made from alloys include nitinol, silicone & nitinol, stainless steel, and elgiloy (cobalt-chromium-nickel Alloy) and nonmetallic stents, made from synthetic polymers such as resins, polyurethane, and silicone, are used as per the requirement as they offer different features.
Due to the high adoption of minimally invasive techniques, such as nonvascular stenting, by healthcare professionals, the market is expected to grow. This can be attributed to the various advantages such as smaller incisions, rapid wound healing, and reduced pain & surgical scars. Smaller incisions and surgical wounds result in lesser complications, which significantly reduces the overall surgery cost. Moreover, minimally invasive surgeries result in reduced hospital stay, which ultimately lowers the risk of hospital-acquired infections in patients. This helps reduce the overall healthcare expenditure of patients.
This product will be delivered within 1-3 business days.
Technological advancements such as the development of radioactive & biodegradable stents, advanced stent designs & change in material composition, and newer stent placement techniques, such as Endoscopic Ultrasound-guided (EUS) stenting, are expected to help in the growth of the non-vascular stents market over the forecast period. Various materials such as metallic stents, made from alloys include nitinol, silicone & nitinol, stainless steel, and elgiloy (cobalt-chromium-nickel Alloy) and nonmetallic stents, made from synthetic polymers such as resins, polyurethane, and silicone, are used as per the requirement as they offer different features.
Due to the high adoption of minimally invasive techniques, such as nonvascular stenting, by healthcare professionals, the market is expected to grow. This can be attributed to the various advantages such as smaller incisions, rapid wound healing, and reduced pain & surgical scars. Smaller incisions and surgical wounds result in lesser complications, which significantly reduces the overall surgery cost. Moreover, minimally invasive surgeries result in reduced hospital stay, which ultimately lowers the risk of hospital-acquired infections in patients. This helps reduce the overall healthcare expenditure of patients.
Non-vascular Stents Market Report Highlights
- Biliary stents dominated the market in 2023 due to increasing occurrence of liver and bile duct diseases such as cholangiocarcinoma and gallstones resulting in a rising need for less invasive methods to deal with blockages.
- The gastrointestinal stents segment is expected to register the highest growth over the forecast period owing to surge in the number of cases of gastrointestinal cancer, such as cancer of the esophagus, stomach, gallbladder, small intestine, pancreas, liver, bowel, and anus
- North America is expected to dominate the market during the forecast period owing to the local presence of major market players and robust healthcare infrastructure coupled with a high prevalence of gastrointestinal cancer in the U.S. & Canada.
The leading players in the Non-Vascular Stents market include:
- Medtronic
- BD
- Boston Scientific Corporation
- ELLA - CS, s.r.o.
- CONMED Corporation
- HOBBS MEDICAL, INC
- Cook
- TAEWOONG
- Glaukos Corporation
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Global Non-Vascular Stents Market Variables, Trends, & Scope
Chapter 4. Global Non-Vascular Stents Market: Product Estimates & Trend Analysis
Chapter 5. Globe Non-Vascular Stents Market: End Use Estimates & Trend Analysis
Chapter 6. Globe Non-Vascular Stents Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
The leading players in the Non-Vascular Stents market include:- Medtronic
- BD
- Boston Scientific Corporation
- ELLA - CS, s.r.o.
- CONMED Corporation
- HOBBS MEDICAL, INC
- Cook
- TAEWOONG
- Glaukos Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 1.63 Billion |
| Forecasted Market Value ( USD | $ 2.27 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
